Since commencing operations, Kyrgyzpharmacia has already procured around $25 million worth of pharmaceuticals from international suppliers for distribution within Kyrgyzstan. This has helped provide life-saving medicines to national hospitals, rural health centers, and the general population at more affordable costs than previously available.
By centralizing pharmaceutical supply chains under state management, Kyrgyzpharmacia aims to overcome the country’s health access challenges and deliver quality, low-cost medicines nationwide despite limited resources. Its early successes demonstrate the potential benefits of a centralized national pharmaceutical distributor focused on public access over profits.
Many meetings are being arranged with leading pharmaceutical companies, to discuss improving market access and supply of essential medicines. Delta Medical, a Swiss pharmaceutical company, with offices in Bishkek, has already held meetings with Kyrgyzpharmacia, to coordinate the supply of various specialty pharmaceuticals.
While still a new entity, Kyrgyzpharmacia has emerged as a promising model for improving pharmaceutical availability and affordability within developing countries through coordinated procurement and supply policies.
